id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2021-0012-0004,DEA,DEA-2021-0012,Schedules of Controlled Substances: Placement of Mesocarb in Schedule I,Rule,,2022-11-22T05:00:00Z,2022,11,2022-11-22T05:00:00Z,,2022-11-22T13:27:04Z,2022-25219,0,0,09000064854fbb4f
DEA-2021-0012-0002,DEA,DEA-2021-0012,Mesocarb 8 Factor August 2021,Supporting & Related Material,,2021-08-17T04:00:00Z,2021,8,,,2021-08-17T15:02:59Z,,0,0,0900006484c6c92b
DEA-2021-0012-0003,DEA,DEA-2021-0012,HHS recommendation on Mesocarb Apr 3 2012,Supporting & Related Material,,2021-08-17T04:00:00Z,2021,8,,,2021-08-17T15:05:58Z,,0,0,0900006484c6c92d
DEA-2021-0012-0001,DEA,DEA-2021-0012,Schedules of Controlled Substances: Placement of Mesocarb in Schedule I,Proposed Rule,,2021-08-11T04:00:00Z,2021,8,2021-08-11T04:00:00Z,2021-10-13T03:59:59Z,2021-10-14T01:00:34Z,2021-16489,0,0,0900006484c42141